Pub Date : 2025-11-18DOI: 10.1186/s43088-025-00718-7
Mahitab M. Nageeb, Marwa Abdel-Moniem Amer, Doaa M. Hendawy, Sabah Mohamed Hanafy, Maha Saad Elmenshawi, Gena M. Elmakromy, Dena Mohamed Naguib Abdel Moawed
{"title":"Retraction Note: The alleviative efficacy of sildenafil and chrysin against zinc oxide nanoparticles-provoked hepatic and blood toxicity: role of MyD88/NF-κB1/TNF-α pathway","authors":"Mahitab M. Nageeb, Marwa Abdel-Moniem Amer, Doaa M. Hendawy, Sabah Mohamed Hanafy, Maha Saad Elmenshawi, Gena M. Elmakromy, Dena Mohamed Naguib Abdel Moawed","doi":"10.1186/s43088-025-00718-7","DOIUrl":"10.1186/s43088-025-00718-7","url":null,"abstract":"","PeriodicalId":481,"journal":{"name":"Beni-Suef University Journal of Basic and Applied Sciences","volume":"14 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2025-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://bjbas.springeropen.com/counter/pdf/10.1186/s43088-025-00718-7","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145560847","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-15DOI: 10.1186/s43088-025-00705-y
Menna Elemairy, Enas I. A. Mohamed, Abeer Moawad, Rabab Mohammed
Background
Plants have long been recognized as a rich source for medicinal agents, albeit many plant species have yet to be investigated. The genus Chlorophytum comprises over 215 species of perennial, rhizomatous herbs. The chemical composition and bioactivities of Chlorophytum krookianum remain uncharacterized in the existing scholar literature. This work investigates the phytochemistry and anticancer potential of C. krookianum.
Results
Phytochemical investigation of the unexplored C. krookianum aerial parts afforded the isolation and identification of eight compounds: β-sitosterol (1), stigmasterol (2), β-sitosterol-3-O-β-D-glucopyranoside (3), hydroxytyrosol (4), isovitexin (5), vicenin 2 (6), (25S)-gitonin (7), and vitexin-2″-O-rhamnoside (8). Dichloromethane and n-hexane fractions of C. krookianum aerial parts exhibited anticancer activity against breast (MDA-MB-231) and tongue (HNO-97) carcinoma cell lines. GC–MS analysis of the n-hexane fraction afforded the tentative identification of 41 metabolites with methyl palmitate, methyl 2,4-dimethyltetradecanoate, 6,10,14-trimethyl-2-pentadecanone, lanosterol, and 13-docosenamide as major compounds.
Conclusion
C. krookianum aerial parts, particularly the dichloromethane and n-hexane fractions, could be a potential source for anticancer activity as significant percentage inhibitions are obtained.
植物长期以来一直被认为是药物的丰富来源,尽管许多植物物种尚未被研究。吊兰属包括超过215种多年生根茎草本植物。在现有的学者文献中,吊兰的化学成分和生物活性尚未得到明确的描述。本研究主要探讨了黄菖蒲的植物化学和抗癌潜力。结果通过植物化学研究,分离鉴定出8个化合物:β-谷甾醇(1)、豆甾醇(2)、β-谷甾醇-3- 0 -β- d -葡萄糖吡喃苷(3)、羟基酪醇(4)、异牡荆素(5)、vicenin 2(6)、(25S)-gitonin(7)、牡荆素-2″- o -鼠李糖苷(8)。鸡翅部二氯甲烷和正己烷组分对乳腺(MDA-MB-231)和舌(HNO-97)癌细胞具有抗肿瘤活性。对正己烷部分进行气相色谱-质谱分析,初步鉴定出41种代谢物,主要化合物为棕榈酸甲酯、2,4-二甲基十四酸甲酯、6,10,14-三甲基-2-戊烷酮、羊毛甾醇和13-二十二酰胺。桂花部分,特别是二氯甲烷和正己烷部分,可能是抗癌活性的潜在来源,因为获得了显着的百分比抑制。
{"title":"Phytochemical investigation and anticancer assessment of Chlorophytum krookianum","authors":"Menna Elemairy, Enas I. A. Mohamed, Abeer Moawad, Rabab Mohammed","doi":"10.1186/s43088-025-00705-y","DOIUrl":"10.1186/s43088-025-00705-y","url":null,"abstract":"<div><h3>Background</h3><p>Plants have long been recognized as a rich source for medicinal agents, albeit many plant species have yet to be investigated. The genus <i>Chlorophytum</i> comprises over 215 species of perennial, rhizomatous herbs. The chemical composition and bioactivities of <i>Chlorophytum krookianum</i> remain uncharacterized in the existing scholar literature. This work investigates the phytochemistry and anticancer potential of <i>C. krookianum</i>.</p><h3>Results</h3><p>Phytochemical investigation of the unexplored <i>C. krookianum</i> aerial parts afforded the isolation and identification of eight compounds: <i>β-</i>sitosterol (<b>1</b>), stigmasterol (<b>2</b>), <i>β</i>-sitosterol-3-<i>O</i>-<i>β</i>-D-glucopyranoside (<b>3</b>), hydroxytyrosol (<b>4</b>), isovitexin (<b>5</b>), vicenin 2 (<b>6</b>), (25<i>S</i>)-gitonin (<b>7</b>), and vitexin-2″-<i>O</i>-rhamnoside (<b>8</b>). Dichloromethane and <i>n</i>-hexane fractions of <i>C. krookianum</i> aerial parts exhibited anticancer activity against breast (MDA-MB-231) and tongue (HNO-97) carcinoma cell lines. GC–MS analysis of the <i>n</i>-hexane fraction afforded the tentative identification of 41 metabolites with methyl palmitate, methyl 2,4-dimethyltetradecanoate, 6,10,14-trimethyl-2-pentadecanone, lanosterol, and 13-docosenamide as major compounds.</p><h3>Conclusion</h3><p><i>C. krookianum</i> aerial parts, particularly the dichloromethane and <i>n</i>-hexane fractions, could be a potential source for anticancer activity as significant percentage inhibitions are obtained.</p></div>","PeriodicalId":481,"journal":{"name":"Beni-Suef University Journal of Basic and Applied Sciences","volume":"14 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2025-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://bjbas.springeropen.com/counter/pdf/10.1186/s43088-025-00705-y","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145560883","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-15DOI: 10.1186/s43088-025-00713-y
Muhammad Aasim, Amjad Ali, Furkan Ulaş, Muhammed Tatar, Waqas Liaqat, Muhammad Tanveer Altaf, Mehdi Rahimi
Background
Nanotechnology presents a sustainable paradigm for modern agriculture, utilizing nanoscale materials to combat plant diseases, enhance crop growth, and minimize environmental impact. Among the various synthesis methods, fungi-based nanoparticles (NPs) have garnered significant attention due to their cost-effectiveness, eco-friendliness, and versatility compared to conventional physicochemical approaches.
Main body
Fungi possess unique metabolic pathways that facilitate the biosynthesis of NPs with distinct physicochemical properties, making them highly applicable to agriculture. These fungi-derived NPs exhibit strong and broad-spectrum antimicrobial activity against major phytopathogens, including Fusarium oxysporum, Rhizoctonia solani, and Sclerotinia sclerotiorum. This review comprehensively details the biological mechanisms and agricultural applications of these NPs. Furthermore, it explores the integration of machine learning (ML) to advance the field, demonstrating how ML models optimize synthesis parameters, predict NP stability, and enhance antimicrobial efficacy, thereby paving the way for scalable and standardized production. An advanced bibliometric analysis (2000–2024) underscores the rapid expansion of this research domain, with India emerging as a leading contributor, reflecting a global shift toward sustainable nanotechnology for plant disease management.
Conclusion
By synthesizing insights from fungal nanobiotechnology, AI-driven optimization, and global research trends, this review provides a forward-looking perspective on developing and implementing advanced, eco-friendly strategies for sustainable agriculture.
{"title":"Myconanoparticles: a sustainable strategy for agricultural applications and phytopathogen management","authors":"Muhammad Aasim, Amjad Ali, Furkan Ulaş, Muhammed Tatar, Waqas Liaqat, Muhammad Tanveer Altaf, Mehdi Rahimi","doi":"10.1186/s43088-025-00713-y","DOIUrl":"10.1186/s43088-025-00713-y","url":null,"abstract":"<div><h3>Background</h3><p>Nanotechnology presents a sustainable paradigm for modern agriculture, utilizing nanoscale materials to combat plant diseases, enhance crop growth, and minimize environmental impact. Among the various synthesis methods, fungi-based nanoparticles (NPs) have garnered significant attention due to their cost-effectiveness, eco-friendliness, and versatility compared to conventional physicochemical approaches.</p><h3>Main body</h3><p>Fungi possess unique metabolic pathways that facilitate the biosynthesis of NPs with distinct physicochemical properties, making them highly applicable to agriculture. These fungi-derived NPs exhibit strong and broad-spectrum antimicrobial activity against major phytopathogens, including <i>Fusarium oxysporum</i>, <i>Rhizoctonia solani</i>, and <i>Sclerotinia sclerotiorum</i>. This review comprehensively details the biological mechanisms and agricultural applications of these NPs. Furthermore, it explores the integration of machine learning (ML) to advance the field, demonstrating how ML models optimize synthesis parameters, predict NP stability, and enhance antimicrobial efficacy, thereby paving the way for scalable and standardized production. An advanced bibliometric analysis (2000–2024) underscores the rapid expansion of this research domain, with India emerging as a leading contributor, reflecting a global shift toward sustainable nanotechnology for plant disease management.</p><h3>Conclusion</h3><p>By synthesizing insights from fungal nanobiotechnology, AI-driven optimization, and global research trends, this review provides a forward-looking perspective on developing and implementing advanced, eco-friendly strategies for sustainable agriculture.</p></div>","PeriodicalId":481,"journal":{"name":"Beni-Suef University Journal of Basic and Applied Sciences","volume":"14 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2025-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://bjbas.springeropen.com/counter/pdf/10.1186/s43088-025-00713-y","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145560886","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-15DOI: 10.1186/s43088-025-00715-w
Lamees Ahmed Samy, Abeer Mohammed Ahmed Hassan Zahran, Rasha Mohamad Hosny Shahin, Nermine Magdi Riad, Hend Hamed Tamim
Background
Rheumatoid arthritis pathogenesis involves multifaceted genetic and environmental interactions, with hereditary components contributing 50 to 60% of disease susceptibility. Among non-HLA genetic determinants, polymorphisms in Interleukin-1 receptor (IL-1R)-associated kinase (IRAK1) and Chemokine receptor type 6 (CCR6) genes potentiate vulnerability to autoimmune diseases. So, this research aims at examining the potential role of the single nucleotide variant of IRAK1 and CCR6 genes in RA vulnerability and clarifying their association with disease-related variables. 58 RA cases and 40 healthy controls were recruited. We performed genotyping for IRAK1 rs1059703 via restriction fragment length polymorphism polymerase chain reaction (RFLP-PCR) and CCR6 rs3093024 using amplification-refractory mutation system PCR (ARMS-PCR) methodology.
Results
Statistical analysis demonstrated significant associations for IRAK1 CT + TT vs CC genotypes (P = 0.012) and T allele frequency (P = 0.001) differed substantially between RA patients and healthy controls. Conversely, CCR6 genotype/allele distributions showed no significant intergroup variations. Clinical parameters, including age, disease duration, sex, subcutaneous nodules, interstitial lung disease, Sjogrenʼs syndrome, joint deformity and rheumatoid factor (RF), demonstrated no significant association with either IRAK1 or CCR6 genotypes with exception of a significant link between CCR6 genotypes and anti-CCP positivity (P = 0.049).
Conclusion
The presence of the polymorphic genotypes and T allele of IRAK1 gene is associated with increased susceptibility of RA. Variation in CCR6 genotype was not associated with RA. However, the polymorphic variant of CCR6 was associated with positive anti-CCP. Assessing the relationship between RA pathogenesis and additional SNPs in these genes is advised.
{"title":"Association between the single nucleotide variants of IRAK1 and CCR6 gene and the susceptibility to rheumatoid arthritis: a case–control study","authors":"Lamees Ahmed Samy, Abeer Mohammed Ahmed Hassan Zahran, Rasha Mohamad Hosny Shahin, Nermine Magdi Riad, Hend Hamed Tamim","doi":"10.1186/s43088-025-00715-w","DOIUrl":"10.1186/s43088-025-00715-w","url":null,"abstract":"<div><h3>Background</h3><p>Rheumatoid arthritis pathogenesis involves multifaceted genetic and environmental interactions, with hereditary components contributing 50 to 60% of disease susceptibility. Among non-HLA genetic determinants, polymorphisms in Interleukin-1 receptor (IL-1R)-associated kinase (IRAK1) and Chemokine receptor type 6 (CCR6) genes potentiate vulnerability to autoimmune diseases. So, this research aims at examining the potential role of the single nucleotide variant of IRAK1 and CCR6 genes in RA vulnerability and clarifying their association with disease-related variables. 58 RA cases and 40 healthy controls were recruited. We performed genotyping for IRAK1 rs1059703 via restriction fragment length polymorphism polymerase chain reaction (RFLP-PCR) and CCR6 rs3093024 using amplification-refractory mutation system PCR (ARMS-PCR) methodology.</p><h3>Results</h3><p>Statistical analysis demonstrated significant associations for IRAK1 CT + TT vs CC genotypes (<i>P</i> = 0.012) and T allele frequency (<i>P</i> = 0.001) differed substantially between RA patients and healthy controls. Conversely, CCR6 genotype/allele distributions showed no significant intergroup variations. Clinical parameters, including age, disease duration, sex, subcutaneous nodules, interstitial lung disease, Sjogrenʼs syndrome, joint deformity and rheumatoid factor (RF), demonstrated no significant association with either IRAK1 or CCR6 genotypes with exception of a significant link between CCR6 genotypes and anti-CCP positivity (<i>P</i> = 0.049).</p><h3>Conclusion</h3><p>The presence of the polymorphic genotypes and T allele of IRAK1 gene is associated with increased susceptibility of RA. Variation in CCR6 genotype was not associated with RA. However, the polymorphic variant of CCR6 was associated with positive anti-CCP. Assessing the relationship between RA pathogenesis and additional SNPs in these genes is advised.</p></div>","PeriodicalId":481,"journal":{"name":"Beni-Suef University Journal of Basic and Applied Sciences","volume":"14 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2025-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://bjbas.springeropen.com/counter/pdf/10.1186/s43088-025-00715-w","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145560885","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-15DOI: 10.1186/s43088-025-00703-0
Haya Majid, Sajad Ul Islam, Sunil Kohli, Nidhi
Background
Type 2 Diabetes Mellitus (T2DM) is a rapidly growing global health burden. Beyond vascular and metabolic complications, it is increasingly recognized as a major contributor to cognitive impairment and dementia. Cognitive dysfunction in T2DM often goes undetected until advanced stages, limiting effective intervention. Early detection strategies are therefore urgently needed. This study investigated the diagnostic potential of neuroinflammatory, metabolic/insulin signaling, and neuroprotective biomarkers in identifying cognitive impairment among T2DM patients.
Methods
In a tertiary care hospital, 200 participants were enrolled in a case–control study (100 participants in each group). Cognitive performance was assessed by the Montreal Cognitive Assessment (MoCA). The concentrations of HMGB1, IL-1β, TLR4, IL-6, ADAM-10, mTOR, PI3K, Akt, TNF-α, and Klotho in the serum were measured by ELISA. Analysis of correlation and receiver operating characteristic (ROC) curves were performed.
Results
MoCA assessments were lower for patients with T2DM than for controls. Elevated serum concentrations of HMGB1, IL-1β, TLR4, IL-6, ADAM-10, TNF-α, mTOR, and PI3K with lower Akt and Klotho concentrations were observed in the T2DM patients. These biomarkers negatively correlated with MoCA scores (p < 0.001), indicating their potential role in cognitive impairment. ROC analysis identified ADAM-10 (AUC = 0.817), IL-1β (AUC = 0.792), and Klotho (AUC = 0.799) as prominent biomarkers of impairment in cognition.
Conclusion
This study demonstrates that dysregulation of neuroinflammatory and metabolic pathways is strongly associated with cognitive decline in T2DM. Given the rising global prevalence of diabetes and dementia, incorporating serum biomarkers such as ADAM-10, IL-1β, and Klotho into clinical screening may enable earlier identification, risk stratification, and timely intervention in diabetes-associated cognitive impairment.
{"title":"Diagnostic potential of serum biomarkers including HMGB1 and Klotho in cognitive impairment among type 2 diabetes mellitus patients: a case–control study","authors":"Haya Majid, Sajad Ul Islam, Sunil Kohli, Nidhi","doi":"10.1186/s43088-025-00703-0","DOIUrl":"10.1186/s43088-025-00703-0","url":null,"abstract":"<div><h3>Background</h3><p>Type 2 Diabetes Mellitus (T2DM) is a rapidly growing global health burden. Beyond vascular and metabolic complications, it is increasingly recognized as a major contributor to cognitive impairment and dementia. Cognitive dysfunction in T2DM often goes undetected until advanced stages, limiting effective intervention. Early detection strategies are therefore urgently needed. This study investigated the diagnostic potential of neuroinflammatory, metabolic/insulin signaling, and neuroprotective biomarkers in identifying cognitive impairment among T2DM patients.</p><h3>Methods</h3><p>In a tertiary care hospital, 200 participants were enrolled in a case–control study (100 participants in each group). Cognitive performance was assessed by the Montreal Cognitive Assessment (MoCA). The concentrations of HMGB1, IL-1β, TLR4, IL-6, ADAM-10, mTOR, PI3K, Akt, TNF-α, and Klotho in the serum were measured by ELISA. Analysis of correlation and receiver operating characteristic (ROC) curves were performed.</p><h3>Results</h3><p>MoCA assessments were lower for patients with T2DM than for controls. Elevated serum concentrations of HMGB1, IL-1β, TLR4, IL-6, ADAM-10, TNF-α, mTOR, and PI3K with lower Akt and Klotho concentrations were observed in the T2DM patients. These biomarkers negatively correlated with MoCA scores (<i>p</i> < 0.001), indicating their potential role in cognitive impairment. ROC analysis identified ADAM-10 (AUC = 0.817), IL-1β (AUC = 0.792), and Klotho (AUC = 0.799) as prominent biomarkers of impairment in cognition.</p><h3>Conclusion</h3><p>This study demonstrates that dysregulation of neuroinflammatory and metabolic pathways is strongly associated with cognitive decline in T2DM. Given the rising global prevalence of diabetes and dementia, incorporating serum biomarkers such as ADAM-10, IL-1β, and Klotho into clinical screening may enable earlier identification, risk stratification, and timely intervention in diabetes-associated cognitive impairment.</p></div>","PeriodicalId":481,"journal":{"name":"Beni-Suef University Journal of Basic and Applied Sciences","volume":"14 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2025-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://bjbas.springeropen.com/counter/pdf/10.1186/s43088-025-00703-0","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145560882","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-14DOI: 10.1186/s43088-025-00710-1
Matthew Chidozie Ogwu, Matěj Malík, Patrik Olekšák, Pavel Tlustoš, Jiří Patočka
Background
Panaeolus foenisecii (Pers.) R. Maire, commonly known as the brown hay or lawnmower’s mushroom, is a small saprotrophic species common in temperate regions of Europe and North America, colonizing nutrient-rich lawns, meadows, and parklands. Although it belongs to a genus that includes psychoactive mushrooms, recent studies classify it as non-hallucinogenic. Morphologically, it is characterized by a hygrophanous brown cap, mottled dark gills, and ellipsoid warty spores, making it a distinctive yet often overlooked member of urban and rural grassland ecosystems.
Main Body
As a litter-decomposing fungus, Panaeolus foenisecii contributes to nutrient recycling and soil fertility and may act as a bioindicator sensitive to soil pH, composition, and moisture. Chemical analyses have identified serotonin and 5-hydroxytryptophan among its metabolites, compounds associated with antioxidant and anti-inflammatory activity. Their concentrations vary with environmental factors such as temperature, rainfall, and soil mineral content, indicating ecophysiological plasticity. Toxicological data show only mild and transient gastrointestinal symptoms after accidental ingestion in humans or animals, suggesting minimal health risk. Despite lacking culinary or recreational use, the occurrence of bioactive indole derivatives underscores its potential ecological and pharmacological relevance.
Conclusion
Panaeolus foenisecii illustrates the ecological and biochemical diversity within the Panaeolus genus and highlights the need for further investigation of non-hallucinogenic species. Its metabolic profile and environmental sensitivity make it a valuable model for studying fungal adaptation and the ecological significance of indole-based metabolites.
{"title":"Beyond hallucinations: the pharmacological and ecological significance of Panaeolus foenisecii","authors":"Matthew Chidozie Ogwu, Matěj Malík, Patrik Olekšák, Pavel Tlustoš, Jiří Patočka","doi":"10.1186/s43088-025-00710-1","DOIUrl":"10.1186/s43088-025-00710-1","url":null,"abstract":"<div><h3>Background</h3><p><i>Panaeolus foenisecii</i> (Pers.) R. Maire, commonly known as the brown hay or lawnmower’s mushroom, is a small saprotrophic species common in temperate regions of Europe and North America, colonizing nutrient-rich lawns, meadows, and parklands. Although it belongs to a genus that includes psychoactive mushrooms, recent studies classify it as non-hallucinogenic. Morphologically, it is characterized by a hygrophanous brown cap, mottled dark gills, and ellipsoid warty spores, making it a distinctive yet often overlooked member of urban and rural grassland ecosystems.</p><h3>Main Body</h3><p>As a litter-decomposing fungus, <i>Panaeolus foenisecii</i> contributes to nutrient recycling and soil fertility and may act as a bioindicator sensitive to soil pH, composition, and moisture. Chemical analyses have identified serotonin and 5-hydroxytryptophan among its metabolites, compounds associated with antioxidant and anti-inflammatory activity. Their concentrations vary with environmental factors such as temperature, rainfall, and soil mineral content, indicating ecophysiological plasticity. Toxicological data show only mild and transient gastrointestinal symptoms after accidental ingestion in humans or animals, suggesting minimal health risk. Despite lacking culinary or recreational use, the occurrence of bioactive indole derivatives underscores its potential ecological and pharmacological relevance.</p><h3>Conclusion</h3><p><i>Panaeolus foenisecii</i> illustrates the ecological and biochemical diversity within the <i>Panaeolus</i> genus and highlights the need for further investigation of non-hallucinogenic species. Its metabolic profile and environmental sensitivity make it a valuable model for studying fungal adaptation and the ecological significance of indole-based metabolites<i>.</i></p></div>","PeriodicalId":481,"journal":{"name":"Beni-Suef University Journal of Basic and Applied Sciences","volume":"14 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2025-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://bjbas.springeropen.com/counter/pdf/10.1186/s43088-025-00710-1","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145510914","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Antimicrobial resistance (AMR) is a crucial global health threat that reduces the effectiveness of conventional antibiotics and contributes to significant morbidity, mortality, and economic burdens, particularly in low-resource settings. This review harnesses the transformative potential of nanotechnology to mitigate the complex issues of AMR from a multidisciplinary perspective.
Main body of the abstract
Metal-based nanoparticles, such as silver, zinc oxide, and copper oxide, exhibit strong bactericidal activity through mechanisms including membrane disruption, reactive oxygen species generation, and the release of toxic metal ions. Carbon-based nanomaterials, such as graphene oxide, carbon nanotubes, and carbon dots, further enhance antimicrobial efficacy owing to their high surface area and customizable functionalization. Smart nanocarriers, including liposomes, dendrimers, and polymeric nanoparticles, enable targeted drug delivery, co-delivery of synergistic agents, and controlled stimuli-responsive release, thereby improving therapeutic efficacy while limiting systemic toxicity. In addition, nanosensors with colorimetric, electrochemical, fluorescent, and surface-enhanced Raman spectroscopy properties demonstrate significant promise for the rapid and sensitive diagnosis of resistant pathogens, including applications in point-of-care testing. Clinical and preclinical studies have demonstrated the effectiveness of nanoparticle-based treatments against multidrug-resistant infections, including methicillin-resistant Staphylococcus aureus, drug-resistant tuberculosis, Escherichia coli, and Pseudomonas aeruginosa. However, challenges such as toxicity concerns, manufacturing scalability, regulatory uncertainties, and environmental risks are significant issues. Despite these advances, their translation into clinical practice remains limited. Current evidence is largely derived from in vitro and animal studies, with relatively few human trials, and long-term safety data are lacking in this regard. Concerns persist regarding their toxicity, biodistribution, cost, regulatory frameworks, and potential environmental impacts. Furthermore, emerging evidence suggests that bacteria may also develop adaptive responses to nanoparticles. Collectively, these findings underscore the potential of nanotechnology in AMR management while emphasizing the critical need for systematic safety studies, clinical validation, and regulatory standardization.
Short conclusion
Nanotechnology holds significant potential for combating AMR; however, its clinical success and translation depend on bridging the gap between laboratory innovation and safe, equitable, and sustainable clinical application.
{"title":"Harnessing nanotechnology to combat antimicrobial-resistant pathogens: a multidisciplinary approach to strengthen global public health defense systems","authors":"Tolutope Adebimpe Oso, Olalekan John Okesanya, Uthman Okikiola Adebayo, Oluwatobi Babajide Ayelaagbe, Khalifat Boluwatife Obadeyi, Moyosore Esther Ogunmuyiwa-James, Mohamed Mustaf Ahmed, Abdulrahman Kayode Yahaya, Shuaibu Saidu Musa, Clement Ngele Chukwu, Kabiru Olalekan Tajudeen, Don Eliseo Lucero-Prisno III","doi":"10.1186/s43088-025-00707-w","DOIUrl":"10.1186/s43088-025-00707-w","url":null,"abstract":"<div><h3>Background</h3><p>Antimicrobial resistance (AMR) is a crucial global health threat that reduces the effectiveness of conventional antibiotics and contributes to significant morbidity, mortality, and economic burdens, particularly in low-resource settings. This review harnesses the transformative potential of nanotechnology to mitigate the complex issues of AMR from a multidisciplinary perspective.</p><h3>Main body of the abstract</h3><p>Metal-based nanoparticles, such as silver, zinc oxide, and copper oxide, exhibit strong bactericidal activity through mechanisms including membrane disruption, reactive oxygen species generation, and the release of toxic metal ions. Carbon-based nanomaterials, such as graphene oxide, carbon nanotubes, and carbon dots, further enhance antimicrobial efficacy owing to their high surface area and customizable functionalization. Smart nanocarriers, including liposomes, dendrimers, and polymeric nanoparticles, enable targeted drug delivery, co-delivery of synergistic agents, and controlled stimuli-responsive release, thereby improving therapeutic efficacy while limiting systemic toxicity. In addition, nanosensors with colorimetric, electrochemical, fluorescent, and surface-enhanced Raman spectroscopy properties demonstrate significant promise for the rapid and sensitive diagnosis of resistant pathogens, including applications in point-of-care testing. Clinical and preclinical studies have demonstrated the effectiveness of nanoparticle-based treatments against multidrug-resistant infections, including methicillin-resistant <i>Staphylococcus aureus</i>, drug-resistant tuberculosis, <i>Escherichia coli,</i> and <i>Pseudomonas aeruginosa</i>. However, challenges such as toxicity concerns, manufacturing scalability, regulatory uncertainties, and environmental risks are significant issues. Despite these advances, their translation into clinical practice remains limited. Current evidence is largely derived from in vitro and animal studies, with relatively few human trials, and long-term safety data are lacking in this regard. Concerns persist regarding their toxicity, biodistribution, cost, regulatory frameworks, and potential environmental impacts. Furthermore, emerging evidence suggests that bacteria may also develop adaptive responses to nanoparticles. Collectively, these findings underscore the potential of nanotechnology in AMR management while emphasizing the critical need for systematic safety studies, clinical validation, and regulatory standardization.</p><h3>Short conclusion</h3><p>Nanotechnology holds significant potential for combating AMR; however, its clinical success and translation depend on bridging the gap between laboratory innovation and safe, equitable, and sustainable clinical application.</p></div>","PeriodicalId":481,"journal":{"name":"Beni-Suef University Journal of Basic and Applied Sciences","volume":"14 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2025-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://bjbas.springeropen.com/counter/pdf/10.1186/s43088-025-00707-w","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145510518","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Cancer is one of the leading causes of death globally, with the reported numbers rising every year. Although the medical fraternity has made considerable progress in early detection and treatment interventions, the numbers are expected to increase drastically by 2040. The most prevalent cause of mortality in people with diverse cancer types is likely multidrug resistance (MDR). As per recent reports, there have been increased incidences of cancer being reported globally, with projections of low-Human Development Index (HDI) countries being affected more in the near future.
Main body
The existing literature has cited the possible use of individual nutrients for the treatment of cancer along with conventional chemotherapeutic interventions. Nutraceuticals have also been shown to target signalling pathways such as activator protein-1 (AP-1) and nuclear factor kappa B (NF-κB) and mitigate progression of MDR. Evidence from various studies has corroborated that nutraceuticals have immense potential to be used as chemosensitizers that can facilitate treatment efficacy. In this review article, we have enlisted the various mechanisms that lead to the development of resistance against chemotherapeutic drugs in cancer cells and subsequently focus on the impact of the dietary intervention/supplementation with functional foods on those mechanisms.
Conclusion
Through this review, we try to address the need for a more detailed study to ameliorate MDR amongst cancer patients and how nutritional supplements and dietary changes can play a complementary role in defining the possible treatment pathway. This structured approach highlights the importance of food at a molecular level and emphasizes the need for more focused and detailed evaluation in the future.